Emcitaben 1gm Injection
Marketer
RPG Life Sciences Ltd
Salt Composition
Gemcitabine (1gm)
Overview Emcitaben 1gm Injection
Oncaspar 1g Injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is strictly by injection from a healthcare professional. Dosage and frequency are determined by your physician based on your condition and may vary. Adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. This medication can lower blood cell counts, raising infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid levels, are essential. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any infection medications, before commencing treatment. Significant drug interactions are possible; disclose all medications you are taking. This injection is contraindicated during pregnancy and breastfeeding; effective contraception for both partners is crucial throughout treatment.
Uses of Emcitaben 1gm Injection
Lung cancer (non-small cell), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Emcitaben 1gm Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Emcitaben 1gm Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Emcitaben 1gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Emcitaben 1gm Injection works:
Emcitaben 1gm Injection disrupts cancer cell DNA and RNA synthesis by replacing essential components. This action halts the proliferation and growth of cancerous cells.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Emcitaben 1gm Injection and alcohol may lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Administering Emcitaben 1gm Injection during pregnancy poses a confirmed risk to the fetus. Its use is therefore contraindicated, except in exceptional, life-threatening circumstances where the potential benefits outweigh the known hazards, as determined by a physician. Always seek medical advice.
Breast feedingUNSAFE
Administration of Emcitaben 1gm Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Administering Emcitaben 1gm Injection may induce drowsiness, blurred vision, and dizziness. Driving is contraindicated if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Emcitaben 1gm Injection use in individuals with renal impairment is scarce. Physician consultation is necessary. Pre-treatment and post-treatment kidney function assessments are recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Emcitaben 1gm Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Emcitaben 1gm Injection :
NA
Facts to Know About Emcitaben 1gm Injection
| Label | Value |
|---|---|
| Chemical Type | Modified Cytosine |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavioral Class | Metabolic antagonists |
3,018 People bought this recently